The extensive intratumor heterogeneity revealed by sequencing cancer genomes is an essential determinant of tumor progression, diagnosis, and treatment. What maintains heterogeneity remains an open question because competition within a tumor leads to a strong selection for the fittest subclone. Cancer cells also cooperate by sharing molecules with paracrine effects, such as growth factors, and heterogeneity can be maintained if subclones depend on each other for survival. Without strict interdependence between subclones, however, nonproducer cells can free-ride on the growth factors produced by neighboring producer cells, a collective action problem known in game theory as the "tragedy of the commons," which has been observed in microbial c...
International audienceExplaining the emergence and maintenance of intratumor heterogeneity is an imp...
Tumorigenesis is a dynamic biological process that involves distinct cancer cell subpopulations prol...
Intrinsic and adaptive drug-resistance mechanisms allow human tumors to evade treatment through the ...
Intratumour heterogeneity (ITH), referring to coexistence of different cell subpopulations in a sing...
Evolutionary game theory (EGT) describes dynamics in populations in which individual fitness can cha...
Anti-cancer therapies promote clonal selection of resistant cells that evade treatment. Effective th...
While it is widely acknowledged that intratumor heterogeneity is mostly generated by genomic instabi...
SUMMARY Cancers arise through a process of somatic evolution that can result in substantial sub-clon...
Cancers exhibit a remarkable degree of intratumoral heterogeneity (ITH), which results from complex ...
The development of a cancerous tumor requires affected cells to collectively display an assortment o...
International audienceAccording to the clonal model and Darwinian evolution, cancer cell evolves thr...
Natural selection in cancer often results in the emergence of increasingly malignant tumor cells tha...
Intratumoral heterogeneity (ITH) plays an important role in tumor development and progression. Varia...
Summary: Adaptive drug-resistance mechanisms allow human tumors to evade treatment through selection...
Intratumoral heterogeneity (ITH) has been regarded as a key cause of the failure and resistance of c...
International audienceExplaining the emergence and maintenance of intratumor heterogeneity is an imp...
Tumorigenesis is a dynamic biological process that involves distinct cancer cell subpopulations prol...
Intrinsic and adaptive drug-resistance mechanisms allow human tumors to evade treatment through the ...
Intratumour heterogeneity (ITH), referring to coexistence of different cell subpopulations in a sing...
Evolutionary game theory (EGT) describes dynamics in populations in which individual fitness can cha...
Anti-cancer therapies promote clonal selection of resistant cells that evade treatment. Effective th...
While it is widely acknowledged that intratumor heterogeneity is mostly generated by genomic instabi...
SUMMARY Cancers arise through a process of somatic evolution that can result in substantial sub-clon...
Cancers exhibit a remarkable degree of intratumoral heterogeneity (ITH), which results from complex ...
The development of a cancerous tumor requires affected cells to collectively display an assortment o...
International audienceAccording to the clonal model and Darwinian evolution, cancer cell evolves thr...
Natural selection in cancer often results in the emergence of increasingly malignant tumor cells tha...
Intratumoral heterogeneity (ITH) plays an important role in tumor development and progression. Varia...
Summary: Adaptive drug-resistance mechanisms allow human tumors to evade treatment through selection...
Intratumoral heterogeneity (ITH) has been regarded as a key cause of the failure and resistance of c...
International audienceExplaining the emergence and maintenance of intratumor heterogeneity is an imp...
Tumorigenesis is a dynamic biological process that involves distinct cancer cell subpopulations prol...
Intrinsic and adaptive drug-resistance mechanisms allow human tumors to evade treatment through the ...